Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Market Closed 02-06 16:00:00 EST

3.39

+0.41

+13.76%

盘后3.32

-0.07-2.06%

19:28 EST

High3.51	Low2.84	Vol109.63K
Open2.93	D1 Closing2.98	Amplitude22.38%
Mkt Cap2.40M	Tradable Cap1.94M	Total Shares708.53K
T/O362.61K	T/O Rate19.15%	Tradable Shares572.50K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":3.39,"timestamp":1770411600000,"preClose":2.98,"halted":0,"volume":109629,"hourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.39,"latestTime":"19:28 EST","volume":2884,"amount":9717.6569,"timestamp":1770424119946,"change":-0.07,"changeRate":-0.020649,"amplitude":0.023599},"delay":0,"changeRate":0.13758389261744972,"floatShares":572500,"shares":708525,"eps":-134.4192,"marketStatus":"Market Closed","change":0.41,"latestTime":"02-06 16:00:00 EST","open":2.93,"high":3.5101,"low":2.8433,"amount":362610.1630593,"amplitude":0.223758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-134.4192,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":2.98,"preHourTrading":{"tag":"盘前","latestPrice":2.9264,"preClose":2.975,"latestTime":"08:57 EST","volume":116,"amount":337.89002,"timestamp":1770386263960,"change":-0.0486,"changeRate":-0.016336,"amplitude":0.05042},"postHourTrading":{"tag":"盘后","latestPrice":3.32,"preClose":3.39,"latestTime":"19:28 EST","volume":2884,"amount":9717.6569,"timestamp":1770424119946,"change":-0.07,"changeRate":-0.020649,"amplitude":0.023599},"volumeRatio":0.5993478890280796},"requestUrl":"/m/hq/s/BJDX","defaultTab":"news","newsList":[{"id":"2607727915","title":"Bluejay Diagnostics Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2607727915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607727915?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:50","pubTimestamp":1769647810,"startTime":"0","endTime":"0","summary":"19:50 EST Bluejay Diagnostics (BJDX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-inc-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2607727898","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2607727898","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607727898?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:50","pubTimestamp":1769647800,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nAQN2LJLU7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2606078285","title":"Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2606078285","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606078285?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:00","pubTimestamp":1769518800,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Jan.  27, 2026  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platf","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/27/3226438/0/en/Bluejay-Diagnostics-Announces-1-for-4-Reverse-Stock-Split.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2606424896","title":"Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2606424896","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606424896?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:00","pubTimestamp":1769432454,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals has completed its acquisition of Bluejay Therapeutics, adding the late-stage investigational therapy brelovitug for chronic hepatitis delta virus  to its portfolio. Brelovitug, a fully human monoclonal antibody, holds Breakthrough Therapy designation from the FDA and PRIME designation from the European Medicines Agency. The therapy is currently being evaluated in the global AZURE Phase 3 program, with topline results expected in the second half of 2026. Mirum acquired all outstanding shares of Bluejay through a combination of cash and common stock, with potential additional tiered sales-based milestone payments. The company is also evaluating strategic options for Bluejay’s additional investigational programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL3typFS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","MIRM","BJDX","BK4139"],"gpt_icon":0},{"id":"2595787326","title":"Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production","url":"https://stock-news.laohu8.com/highlight/detail?id=2595787326","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595787326?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:00","pubTimestamp":1767009600,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Dec.  29, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/29/3210856/0/en/Bluejay-Diagnostics-Announces-Completion-of-Commercial-Scale-IL-6-Antibody-Production.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2582385808","title":"Bluejay Diagnostics Reports Q3 Results and Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385808","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385808?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:48","pubTimestamp":1762811318,"startTime":"0","endTime":"0","summary":"An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On November 10, 2025, Bluejay Diagnostics announced its third-quarter financial re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-reports-q3-results-and-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-reports-q3-results-and-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2582287915","title":"Bluejay Diagnostics provides Q3 corporate update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582287915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582287915?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:55","pubTimestamp":1762779358,"startTime":"0","endTime":"0","summary":"Third Quarter 2025 and Recent Corporate Highlights: SYMON-II Pivotal Clinical Study Continues: Bluejay continues patient enrollment in the SYMON-II...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-provides-q3-corporate-update-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-provides-q3-corporate-update-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2582879316","title":"Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879316","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879316?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:30","pubTimestamp":1762777800,"startTime":"0","endTime":"0","summary":"Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184423/0/en/Bluejay-Diagnostics-Corporate-Update-Advancing-Clinical-Milestones-and-Strategic-Partnerships.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2578062935","title":"Bluejay Diagnostics Advances Sepsis Study with IL-6 Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2578062935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578062935?lang=en_us&edition=fundamental","pubTime":"2025-10-28 00:53","pubTimestamp":1761584009,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics, Inc. (($BJDX)) announced an update on their ongoing clinical study. Bluejay Diagnostics, Inc. is conducting a study titled ‘Mu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-sepsis-study-with-il-6-monitoring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-advances-sepsis-study-with-il-6-monitoring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"gpt_icon":0},{"id":"2577753440","title":"Bluejay Diagnostics files to sell 6.93M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2577753440","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577753440?lang=en_us&edition=fundamental","pubTime":"2025-10-24 05:05","pubTimestamp":1761253524,"startTime":"0","endTime":"0","summary":"The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of shares of common sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-6-93m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-files-to-sell-6-93m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575724291","title":"BRIEF-Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575724291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575724291?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:07","pubTimestamp":1760440040,"startTime":"0","endTime":"0","summary":"BRIEF-Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC FilingOct 14  - Bluejay Diagnostics Inc BJDX.O:BLUEJAY DIAGNOSTICS INC - ENTERS INTO SECURITIES PURCHASE AGREEMENT ON OCT 9 - SEC FILINGBLUEJAY DIAGNOSTICS INC - PRIVATE PLACEMENT CLOSED ON OCTOBER 10, 2025 - SEC FILINGSource text: [ID:n0001213900-25-098281]Further company coverage: BJDX.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU2ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575629196","title":"Bluejay Diagnostics Raises $4M in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2575629196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575629196?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:55","pubTimestamp":1760439317,"startTime":"0","endTime":"0","summary":"The latest update is out from Bluejay Diagnostics ( ($BJDX) ). On October 9, 2025, Bluejay Diagnostics, Inc. announced a private placement of its s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-raises-4m-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-raises-4m-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575969142","title":"Bluejay Diagnostics Inc - Private Placement Closed on October 10, 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575969142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575969142?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:20","pubTimestamp":1760437229,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU2ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2575296874","title":"Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296874","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296874?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:17","pubTimestamp":1760437058,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Inc. has announced a $4.5 million private placement priced at-the-market under Nasdaq rules. The company has entered into definitive agreements for the sale of 2,250,000 shares of common stock  and Series F warrants to purchase up to 4,500,000 shares of common stock, at a purchase price of $2.00 per share and accompanying warrant. The Series F warrants have an exercise price of $1.75 per share, are exercisable immediately, and will expire 5.5 years from issuance. Rodman and Renshaw LLC is acting as the exclusive placement agent for the offering. Bluejay Diagnostics intends to use the net proceeds to support FDA approval efforts, research and development activities, and general working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inve","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDLbX90Zk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2574488561","title":"Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574488561","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574488561?lang=en_us&edition=fundamental","pubTime":"2025-10-11 05:16","pubTimestamp":1760130960,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Oct.  10, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3165124/0/en/Bluejay-Diagnostics-Announces-Closing-of-4-5-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QID","NVIW.SI","TQQQ","PSQ","MNQmain","BK4082","BJDX","SQQQ","USAW.SI","QLD","USJW.SI","NQmain","TSYW.SI",".IXIC"],"gpt_icon":1},{"id":"2574195716","title":"Press Release: Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574195716","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574195716?lang=en_us&edition=fundamental","pubTime":"2025-10-10 03:15","pubTimestamp":1760037300,"startTime":"0","endTime":"0","summary":"ACTON, Mass., Oct. 09, 2025  -- Bluejay Diagnostics, Inc.  , a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,250,000 shares of common stock  and Series F warrants to purchase up to 4,500,000 shares of common stock at a purchase price of $2.00 per share of common stock  and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The Series F warrants will have an exercise price of $1.75 per share and will be exercisable immediately upon issuance. The Series F warrants will expire 5.5 years from the date of issuance. The private placement is expected to close on or about October 10, 2025, subject to the satisfaction of customary closing conditions.Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","SQQQ","NQmain","USJW.SI","USAW.SI","TSYW.SI","BK4082","BJDX","QLD",".IXIC","MNQmain","QID","TQQQ","NVIW.SI"],"gpt_icon":1},{"id":"2574682471","title":"Bluejay Diagnostics Shares Jump 116% After Co Expands Partnership With Japan's Sanyoseiko for Sepsis Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2574682471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574682471?lang=en_us&edition=fundamental","pubTime":"2025-10-09 21:37","pubTimestamp":1760017030,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VQ1CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2574151999","title":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2574151999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574151999?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:39","pubTimestamp":1760009978,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air LinesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nL6N3VQ0K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","LU1974910355.USD","LU2506951792.HKD","IE00B775SV38.USD","LU1035773651.USD","AAL","FRPT","LU0068578508.USD","LU2360106780.USD","ORCL","LUV","AKRO","NB","TREX","LU1815336760.USD","BK4548","BK4097","BK4534","LU1935042991.SGD","LU1878469433.USD","DAL","BK4139","LU0444971666.USD","LU0128526141.USD","UAL","LU2108987350.USD","JBLU","SG9999003800.SGD","BJDX","LU2458330169.SGD","LU1267930227.SGD","LU0719512351.SGD","LU0823414551.USD","LU1861214812.USD","LU0029874061.USD","LU0965509010.AUD","LU0070302665.USD","LU1989764664.SGD","LU2023250504.SGD","BK4168","LU1037948897.HKD","ALB","LU0082616367.USD","BK4581","LU2054465674.USD","IE00BMPRXR70.SGD","LU1366192091.USD"],"gpt_icon":1},{"id":"2574315307","title":"Bluejay Diagnostics Inc: Enters Into Agreement to Amend Master Service Agreement and Master Supply Agreement With Sanyoseiko Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2574315307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574315307?lang=en_us&edition=fundamental","pubTime":"2025-10-09 18:30","pubTimestamp":1760005800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUAJKHNM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2574550921","title":"Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2574550921","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574550921?lang=en_us&edition=fundamental","pubTime":"2025-10-09 18:30","pubTimestamp":1760005800,"startTime":"0","endTime":"0","summary":"ACTON, Mass. and YAMANASHI, Japan, Oct.  09, 2025  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient test","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/09/3163975/0/en/Bluejay-Diagnostics-and-SanyoSeiko-Expand-Strategic-Partnership-to-Advance-Commercialization-of-Symphony-Platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.0635},{"period":"1month","weight":0.286},{"period":"3month","weight":-0.4602},{"period":"6month","weight":-0.3946},{"period":"1year","weight":-0.7599},{"period":"ytd","weight":0.2702}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.09176},{"month":2,"riseRate":0.4,"avgChangeRate":0.053539},{"month":3,"riseRate":0.5,"avgChangeRate":-0.104792},{"month":4,"riseRate":0.25,"avgChangeRate":-0.27562},{"month":5,"riseRate":0.25,"avgChangeRate":-0.095203},{"month":6,"riseRate":0.5,"avgChangeRate":-0.162527},{"month":7,"riseRate":0.5,"avgChangeRate":-0.039437},{"month":8,"riseRate":0,"avgChangeRate":-0.219139},{"month":9,"riseRate":0.25,"avgChangeRate":-0.176769},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040237},{"month":11,"riseRate":0,"avgChangeRate":-0.194266},{"month":12,"riseRate":0.2,"avgChangeRate":-0.253394}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}